Table 2

Echocardiographic parameters at baseline and univariate association with overall death (main endpoint), cardiovascular death, and heart failure hospitalization free survival (secondary endpoints)

VariablenStatisticsUnitsaMain endpointTestbCardiovascular deathHF hospitalization free survival
HRLCLUCLP-valueHRLCLUCLP-valueHRLCLUCLP-value
LV ED diameter (mm)11344.4 ± 6.3561.421.041.950.02921.330.981.820.07121.140.881.480.3286
IV septal wall thickness (mm)11316.0 (14.0–18.0)41.180.791.760.40750.950.571.590.84841.070.721.600.7268
LVEF (%)11355.7 ± 12.7100.600.480.76<0.00010.580.470.70<0.00010.670.550.81<0.0001
LV ED volume (mL)113107 ± 37.8381.240.901.700.18271.230.871.740.24061.210.911.610.1904
LV ES volume (mL)11343.0 (29.0–63.0)30Spline0.00620.0220Spline<0.0001Spline<0.0001
E velocity (cm/s)11388.0 (75.0–100)250.940.701.250.65591.130.881.440.33641.050.771.430.7421
Deceleration time (ms)113164 (138–205)600.800.561.140.20670.730.501.060.10050.890.641.220.4637
A velocity (cm/s)5666.4 ± 29.7301.290.642.600.47621.750.585.290.31871.480.782.820.2277
E/A ratio561.27 (0.99–2.17)0.50.970.761.230.79870.870.591.270.46160.860.701.060.1657
eʹ septal wall (cm/s)1124.85 (3.75–6.00)20.760.491.170.20900.670.401.130.13080.780.541.130.1881
eʹ lateral wall (cm/s)1106.00 (5.00–7.10)20.760.511.140.18400.820.571.180.29000.930.681.270.6612
E/eʹ11116.0 (12.5–20.5)8Spline0.08510.0090Spline0.9072Spline0.2710
aʹ1123.67 ± 4.3640.600.390.910.01700.550.330.930.02580.610.410.900.0135
RV ED area (cm2)11118.0 ± 5.005Spline0.01610.0020Spline<0.00010.0016Spline0.0001
RV basal diameter (mm)11137.6 ± 7.1671.330.971.820.07851.631.172.270.00391.441.081.930.0145
RV annulus diameter (mm)11134.7 ± 6.1561.411.041.900.02681.681.272.230.00031.461.141.880.0026
RV free wall thickness (mm)1077.32 ± 1.7821.340.941.900.10881.400.952.070.08671.050.761.430.7814
TAPSE (mm)11016.7 ± 5.5250.720.511.010.05470.640.420.990.04510.700.520.950.0234
RV systolic pressure (mmHg)9042.7 ± 11.6121.290.881.900.19241.180.811.730.37951.100.811.490.5477
RA pressure (mmHg)1097.65 ± 4.6151.701.182.450.00431.891.252.870.00261.801.312.480.0003
Mitral regurgitation11357.5 (65)11.580.465.390.07130.950.273.310.05751.090.402.930.0350
24.8 (28)2+3.200.9111.22.510.708.952.460.896.83
Aortic regurgitation11344.2 (50)12.140.974.730.15371.690.723.950.47761.640.843.180.3337
12.4 (14)2+2.080.745.841.480.474.651.170.443.10
LVOT VTI (cm)11316.8 ± 4.9750.610.410.890.01060.490.290.820.00610.570.380.850.0062
Stroke volume index (mL/m2)11334.6 ± 11.4110.630.440.910.01300.530.320.890.01640.600.400.900.0146
LAVI (mL/m2)11353.0 (43.0–64.0)201.100.771.560.60581.270.881.830.20331.290.951.760.1006
Right atrial area (cm2)11120.0 (16.0–25.3)101.400.942.110.10181.771.282.440.00051.451.081.950.0127
Interatrial septum thickness (mm)1114.27 ± 0.8510.960.631.470.86730.980.551.750.95210.820.531.270.3782
VariablenStatisticsUnitsaMain endpointTestbCardiovascular deathHF hospitalization free survival
HRLCLUCLP-valueHRLCLUCLP-valueHRLCLUCLP-value
LV ED diameter (mm)11344.4 ± 6.3561.421.041.950.02921.330.981.820.07121.140.881.480.3286
IV septal wall thickness (mm)11316.0 (14.0–18.0)41.180.791.760.40750.950.571.590.84841.070.721.600.7268
LVEF (%)11355.7 ± 12.7100.600.480.76<0.00010.580.470.70<0.00010.670.550.81<0.0001
LV ED volume (mL)113107 ± 37.8381.240.901.700.18271.230.871.740.24061.210.911.610.1904
LV ES volume (mL)11343.0 (29.0–63.0)30Spline0.00620.0220Spline<0.0001Spline<0.0001
E velocity (cm/s)11388.0 (75.0–100)250.940.701.250.65591.130.881.440.33641.050.771.430.7421
Deceleration time (ms)113164 (138–205)600.800.561.140.20670.730.501.060.10050.890.641.220.4637
A velocity (cm/s)5666.4 ± 29.7301.290.642.600.47621.750.585.290.31871.480.782.820.2277
E/A ratio561.27 (0.99–2.17)0.50.970.761.230.79870.870.591.270.46160.860.701.060.1657
eʹ septal wall (cm/s)1124.85 (3.75–6.00)20.760.491.170.20900.670.401.130.13080.780.541.130.1881
eʹ lateral wall (cm/s)1106.00 (5.00–7.10)20.760.511.140.18400.820.571.180.29000.930.681.270.6612
E/eʹ11116.0 (12.5–20.5)8Spline0.08510.0090Spline0.9072Spline0.2710
aʹ1123.67 ± 4.3640.600.390.910.01700.550.330.930.02580.610.410.900.0135
RV ED area (cm2)11118.0 ± 5.005Spline0.01610.0020Spline<0.00010.0016Spline0.0001
RV basal diameter (mm)11137.6 ± 7.1671.330.971.820.07851.631.172.270.00391.441.081.930.0145
RV annulus diameter (mm)11134.7 ± 6.1561.411.041.900.02681.681.272.230.00031.461.141.880.0026
RV free wall thickness (mm)1077.32 ± 1.7821.340.941.900.10881.400.952.070.08671.050.761.430.7814
TAPSE (mm)11016.7 ± 5.5250.720.511.010.05470.640.420.990.04510.700.520.950.0234
RV systolic pressure (mmHg)9042.7 ± 11.6121.290.881.900.19241.180.811.730.37951.100.811.490.5477
RA pressure (mmHg)1097.65 ± 4.6151.701.182.450.00431.891.252.870.00261.801.312.480.0003
Mitral regurgitation11357.5 (65)11.580.465.390.07130.950.273.310.05751.090.402.930.0350
24.8 (28)2+3.200.9111.22.510.708.952.460.896.83
Aortic regurgitation11344.2 (50)12.140.974.730.15371.690.723.950.47761.640.843.180.3337
12.4 (14)2+2.080.745.841.480.474.651.170.443.10
LVOT VTI (cm)11316.8 ± 4.9750.610.410.890.01060.490.290.820.00610.570.380.850.0062
Stroke volume index (mL/m2)11334.6 ± 11.4110.630.440.910.01300.530.320.890.01640.600.400.900.0146
LAVI (mL/m2)11353.0 (43.0–64.0)201.100.771.560.60581.270.881.830.20331.290.951.760.1006
Right atrial area (cm2)11120.0 (16.0–25.3)101.400.942.110.10181.771.282.440.00051.451.081.950.0127
Interatrial septum thickness (mm)1114.27 ± 0.8510.960.631.470.86730.980.551.750.95210.820.531.270.3782

Values are percentage (frequency), mean ± standard deviation, or median (first—third quartile).

ED, end-diastolic; ES, end-systolic; GLS, global longitudinal strain; HR, hazard ratio; LCL (and UCL), lower (and upper) confidence limits; LAVI, left atrial volume index; LA, left atrium; LV, left ventricle; LVEF, left ventricle ejection fraction; RA, right atrium; RV, right ventricle; TAPSE, tricuspid annular plane excursion; VTI, velocity-time integral.

aThe units of change in the continuous explanatory variable for which the customized hazard ratio is estimated.

bKolmogorov-type supremum test, derived from cumulative sums of martingale residuals to assess the functional form of a covariate.

Table 2

Echocardiographic parameters at baseline and univariate association with overall death (main endpoint), cardiovascular death, and heart failure hospitalization free survival (secondary endpoints)

VariablenStatisticsUnitsaMain endpointTestbCardiovascular deathHF hospitalization free survival
HRLCLUCLP-valueHRLCLUCLP-valueHRLCLUCLP-value
LV ED diameter (mm)11344.4 ± 6.3561.421.041.950.02921.330.981.820.07121.140.881.480.3286
IV septal wall thickness (mm)11316.0 (14.0–18.0)41.180.791.760.40750.950.571.590.84841.070.721.600.7268
LVEF (%)11355.7 ± 12.7100.600.480.76<0.00010.580.470.70<0.00010.670.550.81<0.0001
LV ED volume (mL)113107 ± 37.8381.240.901.700.18271.230.871.740.24061.210.911.610.1904
LV ES volume (mL)11343.0 (29.0–63.0)30Spline0.00620.0220Spline<0.0001Spline<0.0001
E velocity (cm/s)11388.0 (75.0–100)250.940.701.250.65591.130.881.440.33641.050.771.430.7421
Deceleration time (ms)113164 (138–205)600.800.561.140.20670.730.501.060.10050.890.641.220.4637
A velocity (cm/s)5666.4 ± 29.7301.290.642.600.47621.750.585.290.31871.480.782.820.2277
E/A ratio561.27 (0.99–2.17)0.50.970.761.230.79870.870.591.270.46160.860.701.060.1657
eʹ septal wall (cm/s)1124.85 (3.75–6.00)20.760.491.170.20900.670.401.130.13080.780.541.130.1881
eʹ lateral wall (cm/s)1106.00 (5.00–7.10)20.760.511.140.18400.820.571.180.29000.930.681.270.6612
E/eʹ11116.0 (12.5–20.5)8Spline0.08510.0090Spline0.9072Spline0.2710
aʹ1123.67 ± 4.3640.600.390.910.01700.550.330.930.02580.610.410.900.0135
RV ED area (cm2)11118.0 ± 5.005Spline0.01610.0020Spline<0.00010.0016Spline0.0001
RV basal diameter (mm)11137.6 ± 7.1671.330.971.820.07851.631.172.270.00391.441.081.930.0145
RV annulus diameter (mm)11134.7 ± 6.1561.411.041.900.02681.681.272.230.00031.461.141.880.0026
RV free wall thickness (mm)1077.32 ± 1.7821.340.941.900.10881.400.952.070.08671.050.761.430.7814
TAPSE (mm)11016.7 ± 5.5250.720.511.010.05470.640.420.990.04510.700.520.950.0234
RV systolic pressure (mmHg)9042.7 ± 11.6121.290.881.900.19241.180.811.730.37951.100.811.490.5477
RA pressure (mmHg)1097.65 ± 4.6151.701.182.450.00431.891.252.870.00261.801.312.480.0003
Mitral regurgitation11357.5 (65)11.580.465.390.07130.950.273.310.05751.090.402.930.0350
24.8 (28)2+3.200.9111.22.510.708.952.460.896.83
Aortic regurgitation11344.2 (50)12.140.974.730.15371.690.723.950.47761.640.843.180.3337
12.4 (14)2+2.080.745.841.480.474.651.170.443.10
LVOT VTI (cm)11316.8 ± 4.9750.610.410.890.01060.490.290.820.00610.570.380.850.0062
Stroke volume index (mL/m2)11334.6 ± 11.4110.630.440.910.01300.530.320.890.01640.600.400.900.0146
LAVI (mL/m2)11353.0 (43.0–64.0)201.100.771.560.60581.270.881.830.20331.290.951.760.1006
Right atrial area (cm2)11120.0 (16.0–25.3)101.400.942.110.10181.771.282.440.00051.451.081.950.0127
Interatrial septum thickness (mm)1114.27 ± 0.8510.960.631.470.86730.980.551.750.95210.820.531.270.3782
VariablenStatisticsUnitsaMain endpointTestbCardiovascular deathHF hospitalization free survival
HRLCLUCLP-valueHRLCLUCLP-valueHRLCLUCLP-value
LV ED diameter (mm)11344.4 ± 6.3561.421.041.950.02921.330.981.820.07121.140.881.480.3286
IV septal wall thickness (mm)11316.0 (14.0–18.0)41.180.791.760.40750.950.571.590.84841.070.721.600.7268
LVEF (%)11355.7 ± 12.7100.600.480.76<0.00010.580.470.70<0.00010.670.550.81<0.0001
LV ED volume (mL)113107 ± 37.8381.240.901.700.18271.230.871.740.24061.210.911.610.1904
LV ES volume (mL)11343.0 (29.0–63.0)30Spline0.00620.0220Spline<0.0001Spline<0.0001
E velocity (cm/s)11388.0 (75.0–100)250.940.701.250.65591.130.881.440.33641.050.771.430.7421
Deceleration time (ms)113164 (138–205)600.800.561.140.20670.730.501.060.10050.890.641.220.4637
A velocity (cm/s)5666.4 ± 29.7301.290.642.600.47621.750.585.290.31871.480.782.820.2277
E/A ratio561.27 (0.99–2.17)0.50.970.761.230.79870.870.591.270.46160.860.701.060.1657
eʹ septal wall (cm/s)1124.85 (3.75–6.00)20.760.491.170.20900.670.401.130.13080.780.541.130.1881
eʹ lateral wall (cm/s)1106.00 (5.00–7.10)20.760.511.140.18400.820.571.180.29000.930.681.270.6612
E/eʹ11116.0 (12.5–20.5)8Spline0.08510.0090Spline0.9072Spline0.2710
aʹ1123.67 ± 4.3640.600.390.910.01700.550.330.930.02580.610.410.900.0135
RV ED area (cm2)11118.0 ± 5.005Spline0.01610.0020Spline<0.00010.0016Spline0.0001
RV basal diameter (mm)11137.6 ± 7.1671.330.971.820.07851.631.172.270.00391.441.081.930.0145
RV annulus diameter (mm)11134.7 ± 6.1561.411.041.900.02681.681.272.230.00031.461.141.880.0026
RV free wall thickness (mm)1077.32 ± 1.7821.340.941.900.10881.400.952.070.08671.050.761.430.7814
TAPSE (mm)11016.7 ± 5.5250.720.511.010.05470.640.420.990.04510.700.520.950.0234
RV systolic pressure (mmHg)9042.7 ± 11.6121.290.881.900.19241.180.811.730.37951.100.811.490.5477
RA pressure (mmHg)1097.65 ± 4.6151.701.182.450.00431.891.252.870.00261.801.312.480.0003
Mitral regurgitation11357.5 (65)11.580.465.390.07130.950.273.310.05751.090.402.930.0350
24.8 (28)2+3.200.9111.22.510.708.952.460.896.83
Aortic regurgitation11344.2 (50)12.140.974.730.15371.690.723.950.47761.640.843.180.3337
12.4 (14)2+2.080.745.841.480.474.651.170.443.10
LVOT VTI (cm)11316.8 ± 4.9750.610.410.890.01060.490.290.820.00610.570.380.850.0062
Stroke volume index (mL/m2)11334.6 ± 11.4110.630.440.910.01300.530.320.890.01640.600.400.900.0146
LAVI (mL/m2)11353.0 (43.0–64.0)201.100.771.560.60581.270.881.830.20331.290.951.760.1006
Right atrial area (cm2)11120.0 (16.0–25.3)101.400.942.110.10181.771.282.440.00051.451.081.950.0127
Interatrial septum thickness (mm)1114.27 ± 0.8510.960.631.470.86730.980.551.750.95210.820.531.270.3782

Values are percentage (frequency), mean ± standard deviation, or median (first—third quartile).

ED, end-diastolic; ES, end-systolic; GLS, global longitudinal strain; HR, hazard ratio; LCL (and UCL), lower (and upper) confidence limits; LAVI, left atrial volume index; LA, left atrium; LV, left ventricle; LVEF, left ventricle ejection fraction; RA, right atrium; RV, right ventricle; TAPSE, tricuspid annular plane excursion; VTI, velocity-time integral.

aThe units of change in the continuous explanatory variable for which the customized hazard ratio is estimated.

bKolmogorov-type supremum test, derived from cumulative sums of martingale residuals to assess the functional form of a covariate.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close